Abstract:Recent advances suggest that the response of RNA metabolism to stress has an important role in the pathophysiology of neurodegenerative diseases, particularly amyotrophic lateral sclerosis, frontotemporal dementias and Alzheimer disease. RNA-binding proteins (RBPs) control the utilization of mRNA during stress, in part through the formation of membraneless organelles termed stress granules (SGs). These structures form through a process of liquid–liquid phase separation. Multiple biochemical pathways regulate SG biology. The major signalling pathways regulating SG formation include the mammalian target of rapamycin (mTOR)–eukaryotic translation initiation factor 4F (eIF4F) and eIF2α pathways, whereas the pathways regulating SG dispersion and removal are mediated by valosin-containing protein and the autolysosomal cascade. Post-translational modifications of RBPs also strongly contribute to the regulation of SGs. Evidence indicates that SGs are supposed to be transient structures, but the chronic stresses associated with ageing lead to chronic, persistent SGs that appear to act as a nidus for the aggregation of disease-related proteins. We suggest a model describing how intrinsic vulnerabilities within the cellular RNA metabolism might lead to the pathological aggregation of RBPs when SGs become persistent. This process might accelerate the pathophysiology of many neurodegenerative diseases and myopathies, and it suggests new targets for disease intervention.

Lsm7 phase-separated condensates trigger stress granule formation

Friend or Foe: the Role of Stress Granule in Neurodegenerative Disease

Stress-specific differences in assembly and composition of stress granules and related foci

An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function

A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules

Molecular structure of stress granules and their role in the eukaryotic cell

Stress granule formation via ATP depletion-triggered phase separation

Response to stress in biological disorders: Implications of stress granule assembly and function

Targeting stress granules: A novel therapeutic strategy for human diseases

eIF3a Destabilization and TDP-43 Alter Dynamics of Heat-Induced Stress Granules

Regulation of stress granule formation in human oligodendrocytes

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

Asymmetric dimethylation amplifies stress granule assembly via phase separation

G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules

PRMT1 and TDRD3 promote stress granule assembly by rebuilding the protein-RNA interaction network

The involvement of stress granules in aging and aging‐associated diseases

Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock

Stress granules and neurodegeneration

Rational Tuning of the Concentration-independent Enrichment of Prion-like Domains in Stress Granules

Hsp27 Chaperones FUS Phase Separation under the Modulation of Stress-Induced Phosphorylation

Mammalian stress granules and P bodies at a glance